News Release Detail
Mylan Names Prominent Neurosurgeon, Joseph C. Maroon, M.D. to Its Board of Directors
Dr. Maroon currently serves as Professor, Heindl Scholar in Neuroscience and Vice Chairman of the Department of Neurosurgery, University of Pittsburgh Medical Center ("UPMC"). He previously served as Professor and Director of the UPMC Department of Neurosurgery from 1972 through 1984. He joined Allegheny University Hospital as Professor and Chairman of the Department of Neurosurgery and later served as Chairman of the entire Department of Surgery. He remained with Allegheny until 1998, when he rejoined UPMC.
Dr. Maroon received his undergraduate and medical education at the University of Indiana. Following his graduation from medical school in 1965, he served residencies in neurosurgery at Indiana, Georgetown University, and the Radcliffe Infirmary of Oxford University in England. He received a Fellowship from the University of Vermont where he studied microsurgery, as the Given Scholar in Microneurosurgery.
Dr. Maroon was an academic all-american football player at Indiana. He has maintained his interest in the sport by serving as team neurosurgeon for the Pittsburgh Steelers since 1981. His association with the Steelers led him and a colleague, neuropsycholgist Mark Lovell to develop ImPACT©, an innovative computerized diagnostic system used in assessing the severity of concussions. The system has been adopted by the National Football, and National Hockey Leagues, as well as numerous NBA, college and high school teams.
Dr. Maroon has published more than 225 professional articles and authored or co-authored forty chapters of medical text as well as three books. He sits on the editorial boards of five professional journals.
"Dr. Maroon has been recognized both nationally and internationally as one of the world's pre-eminent neurosurgeons," stated Robert J. Coury, Vice Chairman and CEO of Mylan Laboratories Inc. Coury further stated, "Neuroscience has long been an area of focus for Mylan, and as such, the addition of Dr. Maroon to the Board of Directors will bring tremendous value to Mylan, its employees and shareholders."
Mylan Laboratories Inc. is a leading pharmaceutical company that develops, manufactures and markets generic and proprietary prescription products. Mylan has two operating segments that market an extensive line of generic and branded products through four business units: Mylan Pharmaceuticals Inc., Mylan Technologies Inc., UDL Laboratories, Inc. and Bertek Pharmaceuticals Inc. For more information about Mylan, visit www.mylan.com.
CONTACT: FOR: Mylan Laboratories Inc., Pittsburgh
Patricia Sunseri, 412/232-0100
URL: http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Copyright (C) 2003 Business Wire. All rights reserved.